Cargando…
Pharmacotherapy as an adjunct to vitrectomy
Vitreoretinal surgery has advanced extensively from the first days of vitrectomy. During the last decade, new developments in intravitreal pharmacotherapy have created new opportunities to enhance the surgical outcomes of our patients. In this article, we review and discuss some of the supporting ev...
Autores principales: | Villegas, Victor M., González, Mónica P., Berrocal, Audina M., Murray, Timothy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150455/ https://www.ncbi.nlm.nih.gov/pubmed/34104868 http://dx.doi.org/10.1177/25158414211016105 |
Ejemplares similares
-
Vitrectomy using the Eckardt temporary keratoprosthesis
por: Prakhunhungsit, Supalert, et al.
Publicado: (2020) -
Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
por: Villegas, Victor M, et al.
Publicado: (2014) -
Advanced Coats’ disease treated with intravitreal brolucizumab combined with laser photocoagulation
por: Patel, Nimesh A., et al.
Publicado: (2020) -
Adjunct pharmacotherapy for psychotherapy
por: Lochtenberg, Jessica, et al.
Publicado: (2021) -
Giant retinal tears after prior pars plana vitrectomy: management strategies and outcomes
por: Gonzalez, Marco A, et al.
Publicado: (2013)